ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice. 1989

R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
Department of Gynaecology and Obstetrics, School of Medicine, University of Nijmegen, The Netherlands.

A human carcinoma cell line (ETN-1) has been established from a skin metastasis of a moderately differentiated adenocarcinoma of endometrial origin. The cell line has been so far maintained for 27 months through 55 passages, growing as a monolayer as well as in 3-dimensional clusters with a population doubling time of 72 hr. The number of chromosomes per cell varied from 39 to 107 (average number 61.0 +/- 19.8), with a modal number of 46-48. Seven clonal marker chromosomes were detected. Flow cytometric analysis revealed a population of pseudo-tetraploid cells (DNA index 2.1) next to a pseudo-diploid population (DNA index 1.1). The epithelial character of the cells was confirmed by a positive immunocytochemical reaction using monoclonal antibodies (MAbs) to different keratins, the epithelial cell markers BW 495/36 and HMFG-2, as well as by the presence of many junctional complexes. The tumour cells retained a positive reaction with the anti-ovarian carcinoma OV-TL 3, OV-TL 10 and OC 125 MAbs, although the reaction was markedly diminished in comparison with the original tumour. Tumour cells inoculated subcutaneously in nude mice produced well differentiated adenomatous tumour nodules with formation of glandular lumina and basal lamina. Tumour cells injected intraperitoneally produced malignant ascites and regional as well as distant metastases of adenomatous character.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females

Related Publications

R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
January 1984, Gynecologic oncology,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
June 1992, Gynecologic oncology,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
January 1987, The Kurume medical journal,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
September 1988, British journal of cancer,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
August 1989, Gynecologic oncology,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
July 1988, Zhonghua zhong liu za zhi [Chinese journal of oncology],
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
June 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
November 2014, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
May 1974, Journal of the National Cancer Institute,
R F Kruitwagen, and L G Poels, and W N Willemsen, and H J Croes, and D F Smeets, and J L Beck, and A G Hanselaar, and F C Ramaekers, and R Rolland, and P H Jap
April 1982, European journal of cancer & clinical oncology,
Copied contents to your clipboard!